Carole Ben-maimon, President and CEO at Larimar Therapeutics, Inc. (LRMR), bought 63,492 shares at $3.15 ($200K) on 2022-09-16, disclosed to the SEC on 2022-09-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.15 | 31,746 | $100K | 50.0% |
| 2 | $3.15 | 31,746 | $100K | 50.0% |
| Total | $3.15 avg | 63,492 | $200K | 100% |
| Filing → |
| TLGT | BUY | 2017-11-13 | $17K | — | Filing → |